Latest filing published 03 Oct 2023 for Immunome Inc., €1.4M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -76.3%Entry US$21.45 · Close at T+365 US$5.09
- -77.5%Entry US$22.31 · Close at T+365 US$5.01
- -85.2%Entry US$23.09 · Close at T+365 US$3.42
- +25.8%Entry US$13.91 · Close at T+365 US$17.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael Rapp: trading record in brief
This profile gathers the share dealings of Michael Rapp across 3 companies, led by Immunome Inc., ONE Group Hospitality, Inc. and Zynerba Pharmaceuticals, Inc. In total, 31 filings cover trades dated from 27 May 2011 to 2 October 2023.
In open-market terms, that means 19 purchases worth €4.8M on one side and 3 sales worth €5,265 on the other. The totals exclude 4 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants.
In size, the median ticket on the buying side is €234k. Of 16 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. After 8 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -25.6%. These figures describe past trades and do not predict future prices.
The newest entry dates from 3 October 2023: a share grant of €1.4M, in Immunome Inc. The last purchase on record was published on 14 September 2021, which is 1,882 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael Rapp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 253,806 shares@ US$5.9156.5% of flowCommon StockSEC:0001104659-23-106486:0
- 17,500 shares@ US$4.002.5% of flowCommon StockSEC:0001104659-23-004001:0
- 25,962 shares@ US$19.9617.3% of flowCommon StockSEC:0001104659-21-115280:0Canonical exit: 12 Dec 2021 (T+90)
- 22,280 shares@ US$18.468.1% of flowCommon StockSEC:0001104659-21-114881:1Canonical exit: 8 Dec 2021 (T+90)
- 15,500 shares@ US$17.855.4% of flowCommon StockSEC:0001104659-21-114881:2Canonical exit: 9 Dec 2021 (T+90)
- 8,170 shares@ US$17.444.8% of flowCommon StockSEC:0001104659-21-114881:0Canonical exit: 8 Dec 2021 (T+90)
- 19,303 shares@ US$18.326.7% of flowCommon StockSEC:0001104659-21-072620:1Canonical exit: 23 Aug 2021 (T+90)
- 2,300 shares@ US$18.940.8% of flowCommon StockSEC:0001104659-21-072620:2Canonical exit: 24 Aug 2021 (T+90)
- 31,895 shares@ US$18.3818.9% of flowCommon StockSEC:0001104659-21-072620:0Canonical exit: 22 Aug 2021 (T+90)
- 83,332 shares@ US$12.0025.2% of flowCommon StockSEC:0001209191-20-054318:1Canonical exit: 4 Jan 2021 (T+90)
- 555,554 sharesCommon StockSEC:0001209191-20-054318:0
- 5,885 shares@ US$10.453.8% of flowCommon StockSEC:0001615774-18-004593:0Canonical exit: 28 Aug 2018 (T+90)
- 15,000 shares@ US$10.469.4% of flowCommon StockSEC:0001615774-18-003217:0Canonical exit: 31 Jul 2018 (T+90)
- 10,000 shares@ US$9.285.4% of flowCommon StockSEC:0001615774-18-002065:0Canonical exit: 20 Jun 2018 (T+90)
- 15,000 shares@ US$12.9911.6% of flowCommon StockSEC:0001615774-18-000031:0Canonical exit: 2 Apr 2018 (T+90)
- 44,255 shares@ US$9.5925.6% of flowCommon StockSEC:0001615774-17-005848:0Canonical exit: 17 Jan 2018 (T+90)
- 30,000 shares@ US$9.7817.7% of flowCommon StockSEC:0001615774-17-005848:1Canonical exit: 18 Jan 2018 (T+90)
- 25,745 shares@ US$9.9415.6% of flowCommon StockSEC:0001615774-17-005848:2Canonical exit: 21 Jan 2018 (T+90)
- 10,000 shares@ US$15.8510.9% of flowCommon StockSEC:0001144204-16-141808:0Canonical exit: 29 Mar 2017 (T+90)
- 80,467 sharesCommon StockSEC:0001144204-16-082395:0
- 567,505 sharesCommon StockSEC:0001192482-15-000369:0
- 163,056 shares@ US$5.00Common Stock, par value $0.0001 per shareSEC:0001144204-13-055845:0Canonical exit: 14 Jan 2014 (T+90)
- 75,750 sharesCommon Stock, par value $0.0001 per shareSEC:0001144204-13-023997:0
- 121,500 sharesCommon Stock, par value $0.0001 per shareSEC:0001144204-13-023997:1
- 176,000 sharesCommon Stock, par value $0.0001 per shareSEC:0001144204-12-035596:0
25 of 31 declarations
